A clinical study of surpaglottic carcinoma

Abstract

We herein report 38 cases of supraglottic carcinoma treated at Kyushu University from 2009-2012. The three-year overall survival and cause specific survival were 46.9%, 51.0% respectively. The three-year rate of larynx preservation was 36.0%, which significantly worsened due to an advanced T stage. In stage Ⅲ and Ⅳ cases, the rate of larynx preservation in the group undergoing induction chemotherapy followed by chemoradiotherapy was better than that in those undergoing concurrent chemoradiotherapy, but not significantly so.